Accelerating the Discovery and Design of Antimicrobial Peptides with Artificial Intelligence

AGUILERA-PUGA MARIANA DC.; CANCELARICH NATALIA L.; MARANI MARIELA M.; DE LA FUENTE-NUNEZ CÉSAR; PLISSON FABIEN

Computational Drug Discovery and Design

Springer Humana Press

Lugar: Hertfordshire; Año: 2023; p. 329 - 352

Peptides modulate many processes of human physiology targeting ion channels, protein receptors, or enzymes. They represent valuable starting points for the development of new biologics against communicable and non-communicable disorders. However, turning native peptide ligands into druggable materials requires high selectivity and efficacy, predictable metabolism, and good safety profiles. Machine learning models have gradually emerged as cost-effective and time-saving solutions to predict and generate new proteins with optimal properties. In this chapter, we will discuss the evolution and applications of predictive modeling and generative modeling to discover and design safe and effective antimicrobial peptides. We will also present their current limitations and suggest future research directions, applicable to peptide drug design campaigns